Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02386527 · ClinicalTrials.gov registry record
Consortium of Early Arthritis Cohorts USA
A clinical trial, sponsored by Hospital for Special Surgery, New York.
- Terminated
- Registry status
- 119
- Enrollment target
NCT02386527 is a clinical trial that was terminated before completion, run by Hospital for Special Surgery, New York. The registered enrollment target is 119 participants.
The verdict
NCT02386527 was terminated before completion, sponsored by Hospital for Special Surgery, New York.
- TERMINATED
- Registry status
- 119 participants
- Enrollment target
Study Summary
Rheumatoid arthritis (RA) is the most common form of inflammatory arthritis. In the US, it is estimated that as many as 3 million adults may suffer from the disease. Fortunately in the last few years, a shift in strategy toward the earlier institution of disease modifying drugs and the availability of new classes of medications have greatly improved the outcomes that can be expected by most patients. The goal of treatment now aims toward achieving the lowest possible level of arthritis disease activity and even remission, if possible as early on as possible. Research has shown that this translates into minimized joint damage and enhanced physical function and quality of life for the RA patient. This also requires that a diagnosis of RA be made as early on as possible, and herein lies the challenge, i.e. identifying the RA patient early on in the course of their disease.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 119 participants |
| Start Date | 2014-12-01 |
| Est. Completion | 2024-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02386527
The ClinicalTrials.gov registry entry for NCT02386527 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 119 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Hospital for Special Surgery, New York, which has 194 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02386527 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02386527 about?
NCT02386527 is a clinical study titled "Consortium of Early Arthritis Cohorts USA". Rheumatoid arthritis (RA) is the most common form of inflammatory arthritis. In the US, it is estimated that as many as 3 million adults may suffer from the disease. Fortunately in the last few years, a shift in strategy toward the earlier institution of disease modifying drugs and the availability ...
What is the current status of trial NCT02386527?
This trial is currently terminated. The enrollment target is 119 participants. The study started on 2014-12-01. Estimated completion is 2024-04.
Who is sponsoring clinical trial NCT02386527?
This trial is sponsored by Hospital for Special Surgery, New York, which has 194 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.